MESA LABORATORIES INC /CO/

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

MLAB$136.91+7.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income

(in thousands, except per share data)

	Three Months Ended September 30,		Six Months Ended September 30,
	2026	2025	2026	2025
Revenues	$62,336	$60,737	$122,474	$120,280
Cost of revenues	22,458	23,406	43,584	46,010
Gross profit	39,878	37,331	78,890	74,270
Operating expenses:
Selling	9,825	9,796	19,697	20,729
General and administrative	16,614	17,763	33,998	35,721
Research and development	5,051	5,048	9,776	10,032
Total operating expenses	31,490	32,607	63,471	66,482
Operating income	8,388	4,724	15,419	7,788
Non-operating expenses (income):
Interest expense and amortization of debt issuance costs	2,137	2,862	4,500	5,060
Other expenses (income), net	217	(137)	532	(6,283)
Total non-operating expenses (income), net	2,354	2,725	5,032	(1,223)
Earnings before income taxes	6,034	1,999	10,387	9,011
Income tax expense (benefit)	1,693	(477)	3,216	1,793
Net income	$4,341	$2,476	$7,171	$7,218
Earnings per share:
Basic	$0.77	$0.45	$1.28	$1.32
Diluted	$0.75	$0.45	$1.25	$1.30
Weighted-average common shares outstanding:
Basic	5,644	5,512	5,620	5,488
Diluted	5,760	5,535	5,722	5,543

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.